Literature DB >> 31368294

Neurobiological commonalities and distinctions among 3 major psychiatric disorders: a graph theoretical analysis of the structural connectome

Shuai Wang1, Gaolang Gong1, Suyu Zhong1, Jia Duan1, Zhiyang Yin1, Miao Chang1, Shengnan Wei1, Xiaowei Jiang1, Yifang Zhou1, Yanqing Tang1, Fei Wang1.   

Abstract

Background: White matter network alterations have increasingly been implicated in major depressive disorder, bipolar disorder and schizophrenia. The aim of this study was to identify shared and distinct white matter network alterations among the 3 disorders.
Methods: We used analysis of covariance, with age and gender as covariates, to investigate white matter network alterations in 123 patients with schizophrenia, 123 with bipolar disorder, 124 with major depressive disorder and 209 healthy controls.
Results: We found significant group differences in global network efficiency (F = 3.386, p = 0.018), nodal efficiency (F = 8.015, p < 0.001 corrected for false discovery rate [FDR]) and nodal degree (F = 5.971, pFDR < 0.001) in the left middle occipital gyrus, as well as nodal efficiency (F = 6.930, pFDR < 0.001) and nodal degree (F = 5.884, pFDR < 0.001) in the left postcentral gyrus. We found no significant alterations in patients with major depressive disorder. Post hoc analyses revealed that compared with healthy controls, patients in the schizophrenia and bipolar disorder groups showed decreased global network efficiency, nodal efficiency and nodal degree in the left middle occipital gyrus. Furthermore, patients in the schizophrenia group showed decreased nodal efficiency and nodal degree in the left postcentral gyrus compared with healthy controls. Limitations: Our findings could have been confounded in part by treatment differences.
Conclusion: Our findings implicate graded white matter network alterations across the 3 disorders, enhancing our understanding of shared and distinct pathophysiological mechanisms across diagnoses and providing vital insights into neuroimaging-based methods for diagnosis and research.
© 2020 Joule Inc. or its licensors

Entities:  

Mesh:

Year:  2020        PMID: 31368294      PMCID: PMC6919917          DOI: 10.1503/jpn.180162

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  58 in total

Review 1.  Mapping brain asymmetry.

Authors:  Arthur W Toga; Paul M Thompson
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

2.  Rich-club organization of the human connectome.

Authors:  Martijn P van den Heuvel; Olaf Sporns
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

Review 3.  Right-left asymmetrics in the brain.

Authors:  A M Galaburda; M LeMay; T L Kemper; N Geschwind
Journal:  Science       Date:  1978-02-24       Impact factor: 47.728

4.  Language lateralization in schizophrenia, an fMRI study.

Authors:  I E Sommer; N F Ramsey; R S Kahn
Journal:  Schizophr Res       Date:  2001-10-01       Impact factor: 4.939

5.  Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Authors:  Deanna M Barch; Julia M Sheffield
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 6.  White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies.

Authors:  Ming Wei Tham; Puay San Woon; Min Yi Sum; Tih-Shih Lee; Kang Sim
Journal:  J Affect Disord       Date:  2010-10-02       Impact factor: 4.839

7.  Alterations of superficial white matter in schizophrenia and relationship to cognitive performance.

Authors:  Arash Nazeri; M Mallar Chakravarty; Daniel Felsky; Nancy J Lobaugh; Tarek K Rajji; Benoit H Mulsant; Aristotle N Voineskos
Journal:  Neuropsychopharmacology       Date:  2013-04-16       Impact factor: 7.853

Review 8.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

9.  Altered network efficiency in major depressive disorder.

Authors:  Ming Ye; Peng Qing; Ke Zhang; Guangyuan Liu
Journal:  BMC Psychiatry       Date:  2016-12-17       Impact factor: 3.630

10.  A voxel-based diffusion tensor imaging study of white matter in bipolar disorder.

Authors:  Katie Mahon; Jinghui Wu; Anil K Malhotra; Katherine E Burdick; Pamela DeRosse; Babak A Ardekani; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

View more
  5 in total

1.  Negative symptoms are associated with modularity and thalamic connectivity in schizophrenia.

Authors:  Adem Bayrakçı; Nabi Zorlu; Merve Karakılıç; Funda Gülyüksel; Berna Yalınçetin; Elif Oral; Fazıl Gelal; Emre Bora
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-03       Impact factor: 5.270

Review 2.  Genetics and neurobiology of eating disorders.

Authors:  Cynthia M Bulik; Jonathan R I Coleman; J Andrew Hardaway; Lauren Breithaupt; Hunna J Watson; Camron D Bryant; Gerome Breen
Journal:  Nat Neurosci       Date:  2022-05-06       Impact factor: 28.771

3.  Altered Topological Properties of Grey Matter Structural Covariance Networks in Complete Thoracic Spinal Cord Injury Patients: A Graph Theoretical Network Analysis.

Authors:  Wen-Li Wang; Yu-Lin Li; Mou-Xiong Zheng; Xu-Yun Hua; Jia-Jia Wu; Fei-Fei Yang; Nan Yang; Xia He; Li-Juan Ao; Jian-Guang Xu
Journal:  Neural Plast       Date:  2021-02-01       Impact factor: 3.599

4.  Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder.

Authors:  Yanzhuo Song; Jingyu Yang; Miao Chang; Yange Wei; Zhiyang Yin; Yue Zhu; Yuning Zhou; Yifang Zhou; Xiaowei Jiang; Feng Wu; Lingtao Kong; Ke Xu; Fei Wang; Yanqing Tang
Journal:  Front Psychiatry       Date:  2022-09-14       Impact factor: 5.435

Review 5.  Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.

Authors:  Fanglin Guan; Tong Ni; Weili Zhu; L Keoki Williams; Long-Biao Cui; Ming Li; Justin Tubbs; Pak-Chung Sham; Hongsheng Gui
Journal:  Mol Psychiatry       Date:  2021-06-30       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.